Trial Profile
A Multicenter, Randomized, Open-label, Prospective Trial to Evaluate the Safety and Tolerability of Donepezil 23 mg With or Without Intermediate Dose Titration in Patients With Alzheimer's Disease Taking Donepezil Hydrochloride 10 mg
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Dec 2021
Price :
$35
*
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Acronyms ODESA
- 06 Aug 2018 Status changed from active, no longer recruiting to completed.
- 15 Jul 2016 Planned End Date changed from 1 Apr 2016 to 1 Oct 2016.
- 15 Jul 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Jul 2016.